Candidemia after cardiac surgery in the intensive care unit: An observational study

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 3, 2011, Pages 374-378

  Pasero, Daniela ^a   de Rosa, Francesco Giuseppe ^a   Rana, Nerlep Kaur ^a   Fossati, Lucina ^b   Davi, Alessandra ^a   Rinaldi, Mauro ^a   Di Perri, Giovanni ^a   Ranieri, V Marco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Candidemia; Cardiac surgery; Cardiopulmonary bypass

Indexed keywords

MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDEMIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNGAL DETECTION; HEART SURGERY; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OFF PUMP SURGERY; PARENTERAL NUTRITION; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; CANDIDEMIA; CARDIAC SURGICAL PROCEDURES; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; ITALY; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79952328440     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.257931     Document Type: Article

References (15)

1. Leleu G, Aegerter P, Guidet B. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002;17:168-175.
2. Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003;124:2244-2255.
3. Tortorano AM, Caspani L, Rigoni AL, Biraghi E, Sicignano A, Viviani MA. Candidosis in the intensive care unit: a 20-year survey. J Hosp Infect 2004;57:8-13.
4. De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis 2003;37:208-213.
5. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006;34:857-863.
6. Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA. A bedside scoring system ('Candida score') for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med 2006;34: 730-737.
7. Michalopoulos A, Kriaras J, Geroulanos S. Systemic candidiasis in cardiac surgery patients. Eur J Cardiothorac Surg 1997;11:728-731.
8. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664-670.
9. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
10. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a EuropeanyNorth American multicenter study. J Am Med Assoc 1993;270:2957-2963.
11. McKinnon PS, Goff DA, Kern JW, Devlin JW, Barletta JF, Sierawski SJ, Mosenthal AC, Gore P, Ambegaonkar AJ, Lubowski TJ. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001;136:1401-1408; discussion 1409.
12. Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D. Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002;28:1708-1717.
13. Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nystrom PO, Pittet D, Rogers T, Sandven P, Sganga G, Schaller MD, Solomkin J. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998;24:206-216.
14. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-1596.
15. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995;20:1531-1534.